{"symbol":"ABT","fiscalQuarter":"Q4-2022","reportDate":"2023-01-25","reportTime":"BMO","status":"reported","company":{"name":"Abbott Laboratories","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABT/earnings/Q4-2022","postBrief":{"headline":"Abbott Laboratories Beats on EPS, Stock Down 1.36%","keyNumbers":[{"metric":"EPS","actual":"$1.03","expected":"N/A","surprise":"+14.32%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record, and the analysis is based solely on numerical results."},"guidanceChanges":{"summary":"No forward guidance data is available for this quarter.","changes":[]},"whatItMeans":"Abbott Laboratories reported better-than-expected earnings per share, beating estimates by 14.32%. However, the stock reacted negatively, declining by 1.36%. The lack of revenue data and guidance may have contributed to investor uncertainty.","metaDescription":"Abbott Laboratories (ABT) Q4 2022 earnings: EPS beat by 14.32%. Stock down 1.36%. Full breakdown."}}